WILMINGTON, Del.--(BUSINESS WIRE)-- Incyte Corporation (Nasdaq: INCY) announced that it has scheduled a webcast for 8:00 p.m. ET today, Wednesday, November 10, 2010 to review the INCB28050 Phase II results being presented today at 5:30 p.m. ET during the 2010 ACR/ARHP Annual Scientific Meeting in Atlanta.
The live webcast can be accessed by going to our website at www.incyte.com under Investor Relations, Events and Webcasts. A replay of the webcast will also be available following the event.
Incyte Corporation is a Wilmington, Delaware-based drug discovery and development company focused on developing proprietary small molecule drugs for oncology and inflammation. For additional information on Incyte, visit the Company's web site at www.incyte.com.
Pamela M. Murphy
Vice President, Investor Relations & Corporate Communications
KEYWORDS: United States North America Delaware Georgia
INDUSTRY KEYWORDS: Health Biotechnology Clinical Trials Oncology Pharmaceutical